Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum TWEAK Levels in Acne Vulgaris Treated With Isotretinoin
NCT05684861Phase 2Completed
- Sponsor
- South Valley University
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by South Valley University. Primary endpoint: Serum level of TWEAK at 12 weeks. Started Jan 2022; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05684861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684861.